MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Although allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for myelofibrosis (MF), data are limited on how molecular markers predict transplantation outcomes. We retrospectively evaluated transplantation outcomes of 110 consecutive MF patients who underwent allo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Autores principales: Ali, Haris, Aldoss, Ibrahim, Yang, Dongyun, Mokhtari, Sally, Khaled, Samer, Aribi, Ahmed, Afkhami, Michelle, Al Malki, Monzr M., Cao, Thai, Mei, Matthew, O’Donnell, Margaret, Salhotra, Amandeep, Pullarkat, Vinod, Yang, Lixin, Stein, Anthony S., Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Pillai, Raju, Snyder, David
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2019
Materias:
Transplantation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325305/
https://ncbi.nlm.nih.gov/pubmed/30622146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018026658
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares